<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Peri-aneurysmal CSF was obtained at operation from 13 patients with <z:hpo ids='HP_0002138'>subarachnoid haemorrhage</z:hpo> from ruptured <z:hpo ids='HP_0004944'>intracranial aneurysms</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The 5-hydroxytryptamine <z:chebi fb="68" ids="48706">antagonist</z:chebi> <z:chebi fb="0" ids="6123">ketanserin</z:chebi> inhibited contractions of isolated human intracranial arteries, elicited by this CSF </plain></SENT>
<SENT sid="2" pm="."><plain>The presence of <z:chebi fb="0" ids="28790">5-HT</z:chebi> in CSF was confirmed by high performance liquid chromatography </plain></SENT>
<SENT sid="3" pm="."><plain>The use of <z:chebi fb="0" ids="6123">ketanserin</z:chebi> in the therapy of postoperative <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> is discussed </plain></SENT>
</text></document>